Mayne Pharma Group Ltd
OTC:MAYNF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mayne Pharma Group Ltd
OTC:MAYNF
|
AU |
|
A
|
Allied Technologies Ltd
SGX:A13
|
SG |
|
Australian Oil Company Ltd
ASX:AOK
|
AU |
|
K
|
Kontoor Brands Inc
F:3KO
|
US |
|
O
|
Oji Holdings Corp
DUS:OJI
|
JP |
|
Oji Holdings Corp
OTC:OJIPF
|
JP |
|
O
|
Ordina NV
F:ORA
|
NL |
|
R
|
Ryohin Keikaku Co Ltd
OTC:RYKKF
|
JP |
|
N
|
NewAmsterdam Pharma Company NV
F:KH6
|
NL |
|
I
|
iRhythm Technologies Inc
F:I25
|
US |
|
Teekay Corp
NYSE:TK
|
BM |
Wall St Price Targets
MAYNF Price Targets Summary
Mayne Pharma Group Ltd
According to Wall Street analysts, the average 1-year price target for
MAYNF is 4.37 USD with a low forecast of 4.33 USD and a high forecast of 4.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MAYNF's stock price target?
Price Target
4.37
USD
According to Wall Street analysts, the average 1-year price target for
MAYNF is 4.37 USD with a low forecast of 4.33 USD and a high forecast of 4.5 USD.
What is the Revenue forecast for Mayne Pharma Group Ltd?
Projected CAGR
1%
Over the last 7 years, the compound annual growth rate for Revenue has been -4%. The projected CAGR for the next 3 years is 1%.